NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo ex...
NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo expansion
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Infusion of allogeneic NK cells is a potential immunotherapy for both hematopoietic malignancies and solid tumors. Interactions between killer immunoglobulin-like receptors (KIR) on human NK cells and KIR-ligands on tumor cells influence the magnitude of NK function. To obtain sufficient numbers of NK cells for infusion, several approaches have bee...
Alternative Titles
Full title
NK cells maintain licensing status and are subject to KIR/KIR-ligand inhibition following ex vivo expansion
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5477646
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5477646
Other Identifiers
ISSN
0340-7004
E-ISSN
1432-0851
DOI
10.1007/s00262-016-1864-z
